218 related articles for article (PubMed ID: 27663745)
1. Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).
Jafari Giv M
Cardiovasc Toxicol; 2017 Jan; 17(1):13-24. PubMed ID: 27663745
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-associated cardiomyopathy.
Won S; Hong RA; Shohet RV; Seto TB; Parikh NI
Clin Cardiol; 2013 Dec; 36(12):737-42. PubMed ID: 24037954
[TBL] [Abstract][Full Text] [Related]
3. The colours of amphetamine-induced cardiomyopathy.
Berlot B; Williams MGL; Bucciarelli-Ducci C
J Cardiovasc Med (Hagerstown); 2020 May; 21(5):396-397. PubMed ID: 31895130
[No Abstract] [Full Text] [Related]
4. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis.
Vu NT; Maher L; Zablotska I
J Int AIDS Soc; 2015; 18(1):19273. PubMed ID: 25609214
[TBL] [Abstract][Full Text] [Related]
7. Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.
Indave BI; Sordo L; Bravo MJ; Sarasa-Renedo A; Fernández-Balbuena S; De la Fuente L; Sonego M; Barrio G
Drug Alcohol Rev; 2018 Jan; 37(1):56-69. PubMed ID: 28485090
[TBL] [Abstract][Full Text] [Related]
8. Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study.
Hondebrink L; Nugteren-van Lonkhuyzen JJ; Rietjens SJ; Brunt TM; Venhuis B; Soerdjbalie-Maikoe V; Smink BE; van Riel AJHP; de Vries I
Ann Emerg Med; 2018 Mar; 71(3):294-305. PubMed ID: 28969928
[TBL] [Abstract][Full Text] [Related]
9. Fatal amphetamine-associated cardiotoxicity and its medicolegal implications.
Jacobs W
Am J Forensic Med Pathol; 2006 Jun; 27(2):156-60. PubMed ID: 16738435
[TBL] [Abstract][Full Text] [Related]
10. Ice in the Outback: the epidemiology of amphetamine-type stimulant-related hospital admissions and presentations to the emergency department in Hedland, Western Australia.
Monahan C; Coleman M
Australas Psychiatry; 2018 Aug; 26(4):417-421. PubMed ID: 29533079
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy due to ingestion of Adderall.
Marks DH
Am J Ther; 2008; 15(3):287-9. PubMed ID: 18496266
[TBL] [Abstract][Full Text] [Related]
12. The neurotoxicity of amphetamines during the adolescent period.
Teixeira-Gomes A; Costa VM; Feio-Azevedo R; Bastos Mde L; Carvalho F; Capela JP
Int J Dev Neurosci; 2015 Apr; 41():44-62. PubMed ID: 25482046
[TBL] [Abstract][Full Text] [Related]
13. Stimulant Drugs of Abuse and Cardiac Arrhythmias.
Dominic P; Ahmad J; Awwab H; Bhuiyan MS; Kevil CG; Goeders NE; Murnane KS; Patterson JC; Sandau KE; Gopinathannair R; Olshansky B
Circ Arrhythm Electrophysiol; 2022 Jan; 15(1):e010273. PubMed ID: 34961335
[TBL] [Abstract][Full Text] [Related]
14. Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review.
Shadloo B; Amin-Esmaeili M; Haft-Baradaran M; Noroozi A; Ghorban-Jahromi R; Rahimi-Movaghar A
East Mediterr Health J; 2017 May; 23(3):245-256. PubMed ID: 28493273
[TBL] [Abstract][Full Text] [Related]
15. Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.
Du J; Sun H; Huang D; Jiang H; Zhong N; Xu D; Zhao Y; Lin S; Wang W; Du Z; Zhao M; Hser YI
Drug Alcohol Depend; 2014 Oct; 143():44-50. PubMed ID: 25081602
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.
Reddy PKV; Ng TMH; Oh EE; Moady G; Elkayam U
J Am Heart Assoc; 2020 Jun; 9(11):e016704. PubMed ID: 32468897
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
[TBL] [Abstract][Full Text] [Related]
18. Delusional infestation following misuse of prescription stimulants.
Stanciu CN; Penders TM; Oxentine HN
Psychosomatics; 2015; 56(2):210-2. PubMed ID: 25262039
[No Abstract] [Full Text] [Related]
19. Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction.
Reddy PK; Chau E; Patel SV; Yang K; Ng TM; Elkayam U
Am J Cardiol; 2021 Sep; 154():86-91. PubMed ID: 34233837
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Left Ventricular Assist Device in the Recovery of Severe Amphetamine-Associated Dilated Cardiomyopathy.
Soucy-Giguère MC; Cinq-Mars A; Charbonneau É; Voisine P; Beaudoin J; Dubois M; Sénéchal M
Can J Cardiol; 2020 Feb; 36(2):317.e5-317.e7. PubMed ID: 31932114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
